Nevro to Present at Upcoming Conferences

Nevro Corp. (NYSE: NVRO) announced that Keith Grossman, its Chairman and CEO, will present at two major healthcare conferences.

Rhea-AI Summary

Nevro Corp. (NYSE: NVRO) announced that Keith Grossman, its Chairman and CEO, will present at two major healthcare conferences. These include the Wells Fargo 2020 Virtual Healthcare Conference on September 9, 2020, at 4:00 PM ET, and the Morgan Stanley 18th Annual Global Healthcare Conference on September 14, 2020, at 3:00 PM ET. Live webcasts will be available on Nevro’s website, with replays accessible for 14 days. Nevro specializes in innovative solutions for chronic pain management, notably through its Senza spinal cord stimulation system.

Argus Session date unavailable

+4.37% session move Open Argus

Details

News Market Reaction – NVRO

The recorded move for NVRO in the trading session of this news was +4.37%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Sept. 1, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the following conferences:

Wells Fargo 2020 Virtual Healthcare Conference
Wednesday, Sept. 9, 2020 at 4:00 pm ET

Morgan Stanley 18^th Annual Global Healthcare Conference
Monday, Sept. 14, 2020 at 3:00 pm ET

A live webcast of these events will be available on the Investors section of Nevro's website at www.nevro.com.  A webcast replay will be available approximately one hour after each live webcast ends and will be accessible for approximately 14 days.

About Nevro
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain.  Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in ≥65% of patients across six peer-reviewed clinical studies.  The Senza^® System, Senza II™ System, and the Senza^® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10^® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp. 

To learn more about Nevro, connect with us on LinkedIn, Twitter, Facebook and Instagram.

Investor Relations:
Juliet Cunningham
Vice President, Investor Relations
+1 650-433-3247
ir@nevro.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/nevro-to-present-at-upcoming-conferences-301121529.html

SOURCE Nevro Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Nevro presenting at the Wells Fargo 2020 Virtual Healthcare Conference?

Nevro will present at the Wells Fargo 2020 Virtual Healthcare Conference on September 9, 2020, at 4:00 PM ET.

What time is Nevro's presentation at the Morgan Stanley Global Healthcare Conference?

Nevro's presentation at the Morgan Stanley 18th Annual Global Healthcare Conference is scheduled for September 14, 2020, at 3:00 PM ET.

Where can I watch Nevro's conference presentations?

You can watch Nevro's conference presentations via live webcasts available on their official website.

What technologies does Nevro use for chronic pain treatment?

Nevro uses the Senza spinal cord stimulation system, featuring HF10 therapy, for chronic pain treatment.

How effective is Nevro's HF10 therapy?

HF10 therapy from Nevro has shown the ability to reduce or eliminate opioids in 65% of patients across six peer-reviewed studies.